Gastroenterologyceramidesgut microbiota
Modulating MASLD Risk in PNPLA3I148M Carriers: The Role of Gut Microbiota and Ceramides
By MedXY|Oct 10, 2026
Genetic susceptibility to metabolic dysfunction-associated steatotic liver disease (MASLD) is amplified by gut microbiota interactions, with ceramides playing a key role; targeted microbial interventions can reverse hepatic injury in at-ris